Karolinska University hospital
Stockholm, Huddinge, Sweden
NCT Number: NCT02233114
Is Yogic Exercises (12 weeks) increasing respiratory function, functional capacity and quality of life in patients with obstructive lung diseases. With follow up after 6 months.
Looking for future studies?
Notify Me35 year–85 year
All sexes
Interventional
Not applicable
Stockholm, Huddinge, Sweden
Is Yogic Exercises increasing respiratory function in patients with obstructive lung diseases. Will YE improve respiratory muscle strength, functional capacity, inspiratory and expiratory pressure, lung function, perceived dyspnea, dyspnea-related distress (DD), less frequency of dyspnea and heart rate variability in patients with pulmonary disease. Qualitative content analysis will be performed on approximately 15 interviews with patients participated in the yoga group about their experiences and their benefits perceived/experienced of the yogic exercises
We want to try YE as an alternative treatment in patients with mild to severe pulmonary disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Yogic exercises (YE) - 2 hours per week, 1h in each session
Physiotherapy (low intensity cardiovascular training and strength training) - 2 hours per week, 1 h in each session
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
6 minutes Walking test
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured manually
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Scoring between 0 (worst possible) and 10 (best possible)
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Will be measured using PSS-14 scale
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured with Pittsburgh sleep questionnaire index scale
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured with HADS-scale
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured with public health questionnaire (Folkhälsoenkäten in Swedish)
Time frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Measured with insomnia index scale
Time frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Measured with Polar heart rate monitor
Time frame: After Yoga intervention - one interview, with follow-up after 6 months
Inteviews with participants in yoga Group, and at follow-up also physiotherapy group
Karolinska Institutet
Other
Subjective and Objective Effects After Yogic Exercises
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06461403
Acute Exacerbation of COPD, Asthma
Chicago, Illinois, United States
View Trial DetailsNCT00793676
Asthma, Bronchial Diseases
Colmar, France
View Trial DetailsNCT05803902
Asthma, Atopic Dermatitis
Beijing, Beijing Municipality, China
View Trial Details